文献速递系统性红斑狼疮

系统性红斑狼疮中的肿瘤相关抗原:与临床表现及血清学指标的关系

Tumour-associated antigens in systemic lupus erythematosus: association with clinical manifestations and serological indicators.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

本研究为回顾性研究,纳入149例SLE患者与149例年龄性别匹配的健康对照,检测AFP、CEA、CA19-9、CA125、CA15-3及CYFRA21-1等肿瘤相关抗原。SLE组CA19-9和CYFRA21-1阳性率更高,CA125、CA15-3和CYFRA21-1血清水平升高。TAA阳性SLE患者浆膜腔积液、心包积液、白蛋白尿和血小板减少更常见,抗dsDNA阳性率更低;血小板减少和SCR水平是TAA阳性的独立危险因素。

要点

  • SLE组CA19-9和CYFRA21-1阳性率高于健康对照,CA125、CA15-3和CYFRA21-1血清水平升高。
  • TAA阳性SLE患者浆膜腔积液、心包积液、白蛋白尿和血小板减少更常见,抗dsDNA阳性率更低。
  • 血小板减少和SCR水平是TAA阳性的独立危险因素,CA125阳性率及水平与SLE疾病活动相关。

核心结论

  • SLE患者中部分肿瘤相关抗原的阳性率和血清水平升高,血小板减少和SCR水平是TAA阳性的独立危险因素。

研究设计与样本

  • 本研究为回顾性研究,从电子病历中提取SLE患者临床数据,检测AFP、CEA、CA19-9、CA125、CA15-3和CYFRA21-1等TAA血清水平。
  • TAA阳性定义为血清水平超过相应参考范围上限。
  • 共纳入149例SLE患者(SLE组)和149例年龄、性别匹配的健康对照(对照组)。

主要发现

  • 与健康对照相比,SLE组CA19-9和CYFRA21-1阳性率更高,CA125、CA15-3和CYFRA21-1血清水平升高。
  • TAA阳性的SLE患者较TAA阴性者年龄更大,浆膜腔积液、心包积液、白蛋白尿和血小板减少发生率更高,抗dsDNA阳性率更低。
  • TAA阳性SLE患者SCR、血尿素氮、谷草转氨酶和24小时尿蛋白水平更高,血小板计数和血清白蛋白水平更低。
  • 逻辑回归显示血小板减少和SCR水平是TAA阳性的独立危险因素。
  • CA125阳性率及CA125血清水平与SLE疾病活动相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore the relationship of tumour-associated antigens (TAAs) with the clinical manifestations and serological markers of SLE. METHODS: This was a retrospective study. Clinical data of SLE patients were extracted from the electronic medical records, including serum levels of TAAs such as alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen (CA) 19-9, CA125, CA15-3 and cytokeratin 19-fragments (CYFRA21-1). TAA positivity was defined as serum level exceeding the upper limit of the corresponding reference range. RESULTS: A total of 149 SLE patients (SLE group) and 149 age- and sex-matched healthy subjects (control group) were enrolled. Compared with healthy controls, the SLE group had higher positivity rates for CA19-9 and CYFRA21-1, and elevated serum levels of CA125, CA15-3 and CYFRA21-1. SLE patients with TAA positivity were older, had a higher prevalence of serous effusion, pericardial effusion, albuminuria and thrombocytopenia, and lower positivity rate for anti-dsDNA than patients without TAA positivity. The levels of serum creatinine (SCR), blood urea nitrogen, glutamic oxalate transaminase and 24-h urinary protein were also higher in SLE patients with TAA positivity, but platelet count and serum albumin levels were lower. On logistic regression, thrombocytopenia and SCR levels were identified as independent risk factors for TAA positivity. CA125 positivity rate and serum levels of CA125 were associated with SLE disease activity. CONCLUSION: The positivity rates and serum levels of some TAAs were elevated in SLE, and thrombocytopenia and SCR levels were independent risk factors for TAA positivity.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zhong Y, Liu Z, Ma J, et al. Tumour-associated antigens in systemic lupus erythematosus: association with clinical manifestations and serological indicators. Rheumatology (Oxford). 2024. PMID: 37184876. doi:10.1093/rheumatology/kead224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。